tailieunhanh - Pharmaceutical Substances Syntheses, Patents, Applications - Part 64

Pharmaceutical Substances Syntheses, Patents, Applications - Part 64. Reference containing a collection of 2267 active pharmaceutical ingredients, including those launched recently. Listed alphabetically according to their INNs and established a link between INNs, structure, synthesis and production processes, patent and literature situation, medical use, and trade names. For pharmacists and researchers | Dicloxacillin D 631 GB Daranide Merck Sharp Dohme wfm I Antidrasi SmithKline Beecham Fenamide Farmigea Glaumid SIFI J Daranide Merck-Banyu USA Daranide Merck Dicloxacillin ATC JO1CFO1 Use antibiotic RN 3116-76-5 MF C19H17C12N3O5S MW EINECS 221-488-3 CN 2S- 2a 5a 6ß -6- 3- 2 6-dichlorophenyl -5-methyl-4-isoxazolyl carbonyl amino -3 3-dimethyl-7-oxo-4-thia-1 -azabicyclo heptane-2-carboxylic acid monosodium salt monohydrate RN 13412-64-1 MF C19H16Cl2N3NaO5S H2O MW LD50 875 mg kg M . 4560 mg kg M . 520 mg kg R . 3579 mg kg R . 3 g kg dog . Cl CHO H2N-OH hydroxylamine Cl2 CHClj methyl ocetoacetote NaOCH3 2 6-dichloro- benzaldehyde NaOH ----- 3- 2 6-dich1oro-phenyl -5-methyl-jsoxozole-4-carboxylic ocid 6-aminopeni-cillanic acid Os J00H r i ch3 H ch3 h2n h Reference s US 3 239 507 Beecham GB-prior. . GB 978 299 Beecham appl. addition to GB 905 778 from . BE657 504 Bayer appl. D-prior. . Formulation s cps. 500 mg as sodium salt Trade Name s D Dichlor-Stapenor Bayer F Cefaplus Labif -comb. wfm Diclocil Bristol wfm I Diclo Firma 1 632 D Dicycloverine Diclocil Bristol wfm Diclocillin Aristochimica wfm Diclocillin Lagap wfm Diclocta Lusofarmaco -comb. wfm Dicloeta Lusofarmaco -comb. wfm Diclomax Pulitzer wfm Dicloxapen Magis wfm J Diflor Coli wfm Etadipen Ghimas -comb. wfm Novapen IBP wfm Versaclox Bristol -comb. USA wfm numerous combination preparations Clocil Bristre-Banyu Combipenix Toyo Jozo -comb. Diclex Meiji Staphcillin Banyu Dycill Beecham wfm Dynapen Bristol wfm Pathocil Wyeth wfm Veracillin Ayerst wfm Dicycloverine Dicyclomine ATC A03AA07 Use antispasmodic anticholinergic RN 77-19-0 MF C19H35NO2 MW EINECS 201-009-4 CN 1 1 -bicyclohexyl -1 -carboxylic acid 2- diethylamino ethyl ester hydrochloride RN 67-92-5 MF C19H35NO2 HC1 MW EINECS 200-671-1 LD50 mg kg M . 625 mg kg M . 1290 mg kg R . benzyl cyanide 1 5-dibromo- pentane 1-cyano-1 .